Author

Michael Damrat

University Hospital Cologne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Birgit Sybille GathofiD· 1 shared Britta Eiz-VesperiD· 1 shared Christianne de Lima Borges Moraes· 1 shared Christof ScheidiD· 1 shared Dimitrios L. WagneriD· 1 shared Fawad KhaniD· 1 shared Frank KlawonniD· 1 shared Jan-Malte KleidiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Birgit Sybille GathofORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Next-generation all-in-one CRISPR/Cas9 multiply-edited CD30CAR-T cells:Potency despite risk of translocations

Jan-Malte Kleid, Michael Damrat, Milita Darguzyte, Manuel Rhiel, Natascha E. Stumpf, Tabea Kleitke, Sandra Ammann, Tatjana I. Cornu, Fawad Khan, Tobias Wollmann, Sven Borchmann, Christof Scheid, Christianne de Lima Borges Moraes, Tobias Riët, Sabine Awerkiew, , Renata Stripecke

This study develops next-generation CD30CAR-T cells using CRISPR/Cas9 for multiplex editing, showing high potency but risks of translocations with combined knockouts.

bioRxiv · Feb 27, 2026 · PreprintCancer Biology